2019 Post-ESMO Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 21, 2019--
The “2019 Post-ESMO Report” has been added to ResearchAndMarkets.com’s offering.
2019 Post-ESMO Report features summaries of a few key topics along with commentary from analysts on specific presentations. It also includes a compilation of all data events added in conjunction with the meeting.
Drug Abstracts Covered
Biliary Tract Cancer
Head & Neck Cancer
Non-Small Cell Lung Cancer (NSCLC)
Renal Cell Cancer (RCC)
For more information about this report visit https://www.researchandmarkets.com/r/dsfm55
View source version on businesswire.com:https://www.businesswire.com/news/home/20191121005780/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/21/2019 12:02 PM/DISC: 11/21/2019 12:02 PM